199 related articles for article (PubMed ID: 17996306)
1. Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.
; Repka MX; Chandler DL; Beck RW; Crouch ER; Donahue S; Holmes JM; Lee K; Melia M; Quinn GE; Sala NA; Schloff S; Silbert DI; Wallace DK
Ophthalmology; 2008 Mar; 115(3):577-584.e3. PubMed ID: 17996306
[TBL] [Abstract][Full Text] [Related]
2. Office probing for treatment of nasolacrimal duct obstruction in infants.
Miller AM; Chandler DL; Repka MX; Hoover DL; Lee KA; Melia M; Rychwalski PJ; Silbert DI; ; Beck RW; Crouch ER; Donahue S; Holmes JM; Quinn GE; Sala NA; Schloff S; Wallace DK; Foster NC; Frick KD; Golden RP; Lambert SR; Tien DR; Weakley DR
J AAPOS; 2014 Feb; 18(1):26-30. PubMed ID: 24568978
[TBL] [Abstract][Full Text] [Related]
3. Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age.
; Repka MX; Melia BM; Beck RW; Atkinson CS; Chandler DL; Holmes JM; Khammar A; Morrison D; Quinn GE; Silbert DI; Ticho BH; Wallace DK; Weakley DR
J AAPOS; 2008 Oct; 12(5):445-50. PubMed ID: 18595756
[TBL] [Abstract][Full Text] [Related]
4. Repeat probing for treatment of persistent nasolacrimal duct obstruction.
; Repka MX; Chandler DL; Bremer DL; Collins ML; Lee DH
J AAPOS; 2009 Jun; 13(3):306-7. PubMed ID: 19541274
[TBL] [Abstract][Full Text] [Related]
5. Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.
; Repka MX; Melia BM; Beck RW; Chandler DL; Fishman DR; Goldblum TA; Holmes JM; Perla BD; Quinn GE; Silbert DI; Wallace DK
J AAPOS; 2008 Oct; 12(5):451-5. PubMed ID: 18929305
[TBL] [Abstract][Full Text] [Related]
6. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
Hung CH; Chen YC; Lin SL; Chen WL
Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
[TBL] [Abstract][Full Text] [Related]
7. Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing.
Repka MX; Chandler DL; Holmes JM; Hoover DL; Morse CL; Schloff S; Silbert DI; Tien DR;
Arch Ophthalmol; 2009 May; 127(5):633-9. PubMed ID: 19433712
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.
Pediatric Eye Disease Investigator Group
Arch Ophthalmol; 2012 Dec; 130(12):1525-33. PubMed ID: 23229693
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of balloon catheter dilatation and silicon intubation as the secondary treatment for congenital nasolacrimal duct obstruction after failed primary probing].
Hu M; Wu Q; Fan YW; Cao WW; Lin Q; Yu G
Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):123-8. PubMed ID: 26906708
[TBL] [Abstract][Full Text] [Related]
10. A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction.
Lee KA; Chandler DL; Repka MX; Melia M; Beck RW; Summers CG; Frick KD; Foster NC; Kraker RT; Atkinson S;
Am J Ophthalmol; 2013 Nov; 156(5):1045-50. PubMed ID: 23954210
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
[TBL] [Abstract][Full Text] [Related]
12. Probing for congenital nasolacrimal duct obstruction in older children.
Eshragi B; Fard MA; Masomian B; Akbari M
Middle East Afr J Ophthalmol; 2013; 20(4):349-52. PubMed ID: 24339688
[TBL] [Abstract][Full Text] [Related]
13. Initial nasolacrimal duct probing in children under age 5: cure rate and factors affecting success.
Kashkouli MB; Kassaee A; Tabatabaee Z
J AAPOS; 2002 Dec; 6(6):360-3. PubMed ID: 12506276
[TBL] [Abstract][Full Text] [Related]
14. Dilation probing as primary treatment for congenital nasolacrimal duct obstruction.
Clark RA
J AAPOS; 2002 Dec; 6(6):364-7. PubMed ID: 12506277
[TBL] [Abstract][Full Text] [Related]
15. The results of late probing in congenital nasolacrimal duct obstruction.
Zilelioğlu G; Hoşal BM
Orbit; 2007 Mar; 26(1):1-3. PubMed ID: 17510863
[TBL] [Abstract][Full Text] [Related]
16. Office- or Facility-Based Probing for Congenital Nasolacrimal Duct Obstruction: A Report by the American Academy of Ophthalmology.
Morrison DG; Binenbaum G; Chang MY; Heidary G; Trivedi RH; Galvin JA; Pineles SL
Ophthalmology; 2021 Jun; 128(6):920-927. PubMed ID: 33358412
[TBL] [Abstract][Full Text] [Related]
17. Age-based comparison of successful probing in Nepalese children with nasolacrimal duct obstruction.
Limbu B; Akin M; Saiju R
Orbit; 2010 Feb; 29(1):16-20. PubMed ID: 20302404
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction.
Al-Faky YH; Al-Sobaie N; Mousa A; Al-Odan H; Al-Huthail R; Osman E; Al-Mosallam AR
J AAPOS; 2012 Feb; 16(1):53-7. PubMed ID: 22370666
[TBL] [Abstract][Full Text] [Related]
19. Pushed monocanalicular intubation versus probing for the treatment of simple and incomplete complex types of congenital nasolacrimal duct obstruction in children older than 18 months old.
Eshraghi B; Khalilipour E; Ameli K; Bazvand F; Mirmohammadsadeghi A
Orbit; 2017 Aug; 36(4):218-222. PubMed ID: 28627958
[TBL] [Abstract][Full Text] [Related]
20. The management of nasolacrimal duct obstruction in children between 18 months and 4 years old.
Kushner BJ
J AAPOS; 1998 Feb; 2(1):57-60. PubMed ID: 10532369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
